> Details

Laguens, Rubén; Cabeza Meckert, Patricia; Vera Janavel, Gustavo; De Lorenzi, Andrea; Lascano, Elena; Negroni, Jorge; del Valle, Héctor; Cuniberti, Luis; Martínez, Verónica; Dulbecco, Eduardo; Melo, Carlos; Fernández, Nahuel; Criscuolo, Marcelo; Crottogini, Alberto

Cardiomyocyte hyperplasia after plasmid‐mediated vascular endothelial growth factor gene transfer in pigs with chronic myocardial ischemia

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Cardiomyocyte hyperplasia after plasmid‐mediated vascular endothelial growth factor gene transfer in pigs with chronic myocardial ischemia
  • Contributor: Laguens, Rubén; Cabeza Meckert, Patricia; Vera Janavel, Gustavo; De Lorenzi, Andrea; Lascano, Elena; Negroni, Jorge; del Valle, Héctor; Cuniberti, Luis; Martínez, Verónica; Dulbecco, Eduardo; Melo, Carlos; Fernández, Nahuel; Criscuolo, Marcelo; Crottogini, Alberto
  • imprint: Wiley, 2004
  • Published in: The Journal of Gene Medicine
  • Language: English
  • DOI: 10.1002/jgm.478
  • ISSN: 1099-498X; 1521-2254
  • Keywords: Genetics (clinical) ; Drug Discovery ; Genetics ; Molecular Biology ; Molecular Medicine
  • Origination:
  • Footnote:
  • Description: <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>For over 40 years it has been proposed that cardiomyocyte hyperplasia may occur in hypertrophic human hearts. While this implies that heart myocytes can undergo cytokinesis, evidence of conventional cell division has been exceptionally reported. Recently, we found that gene transfer of vascular endothelial growth factor (VEGF) displays a mitogenic effect on adult cardiomyocytes. In the present study we searched for cardiomyocyte hyperplasia as evidence of VEGF‐induced cardiomyocyte cytokinesis.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Three weeks after implanting an Ameroid constrictor at the origin of the left circumflex artery, 16 pigs were randomized to receive 10 direct intramyocardial injections of 3.8 mg of plasmid encoding for VEGF (pVEGF) or empty plasmid. Five weeks later, hearts were weighed, myocyte diameter was measured in tissue sections, and myocyte length and nuclei number were studied in isolated myocytes. A resting echocardiogram was performed immediately before reoperation and before sacrifice to evaluate global and regional left ventricular function. Investigators were blinded to the study groups and nature of the injectate until the end of data analysis.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>No heart weight differences existed between groups. However, in the ischemic myocardium, pVEGF‐treated hearts had 22% more cardiomyocytes per unit volume and exhibited significantly more oligonucleated (1 or 2 nuclei) cardiomyocytes than hearts receiving empty plasmid.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>In pigs with chronic myocardial ischemia, VEGF gene transfer induced cardiomyocyte cytokinesis, as revealed by cardiomyocyte hyperplasia. Our finding extends the previously reported mitogenic effect of VEGF on adult cardiomyocytes and supports the hypothesis that VEGF may have a therapeutic role in diseases characterized by myocardial cell loss. Copyright © 2004 John Wiley &amp; Sons, Ltd.</jats:p></jats:sec>